contrast agent

Iohexol is an X-ray contrast agent containing varying concentrations of iohexol, which can be used for a variety of imaging applications.

Gadopentetic acid (gadolinium complex) (Gd-DTPA) is an paramagnetic contrast agent commonly implemented by a bolus intravenous injection (i.v.) in Dynamic contrast-enhanced MRI (DCE-MRI) studies.

iosimide is a novel nonionic monomer contrast agent that can induce MV in cells.

Iopanoic acid is an iodine contrast agent and a 5'-Deiodinase inhibitor.

Iodixanol (Visipaque) is a nonionic hydrophilic compound commonly used as a contrast agent during coronary angiography.

Sodium diatrizoate is an iodinated radiopaque X-ray contrast agent used as a diagnostic aid in angiography, urography, and radiography. It induces mitochondrial renewal and oxidative stress through calcium dysregulation and activates apoptosis.

Iopamidol (SQ-13396) is a benzenedicarboxamide compound. It has a role as a radioopaque medium, an environmental contaminant and a xenobiotic.

Gadoteridol (Gd-HP-DO3A) is a gadolinium-based MRI contrast agent that can be used for central nervous system imaging.

Ethylene thiourea (NCIC03372) is a pesticide used in fruit and vegetable production. Ethylene thiourea is also used as a novel contrast agent for MRI studies based on proton chemical exchange-dependent saturation transfer.

Ferumoxytol (Magnetic Black) is a non-gadolinium based contrast agent for use in magnetic resonance imaging applications.

Gadolinium(III) chloride hexahydrate is a contrast agent in magnetic resonance imaging and can be used in medicine, magnetic resonance imaging, liquid crystal displays and other fields. Gadolinium(III) chloride hexahydrate can be used to synthesize complexes and nanomaterials.

Acetrizoic acid (Urokon) is the first monomeric ionic compound used as an X-ray contrast agent.

Iopromide (Iopromidum) is a low osmolar, non-ionic contrast agent for intravascular use.

Gadoxetate Disodium is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging. It is a contrast agent in magnetic resonance imaging (MRI) of the hepatobiliary system. It accumulates in normal, fun

EC-17 (disodium salt), a folate receptor alpha (FRα) targeting contrast agent, exhibits fluorescent properties within the visible light spectrum, characterized by peak excitation and emission wavelengths of 470 520 nm, respectively.

Mangafodipir trisodium can enhance contrast in magnetic resonance imaging (MRI) of the liver, is a contrast agent delivered intravenously.

Sodium Ioxaglate is used as a contrast agent.

Ioforminol, also known as GE-145 and AN-113111, is a new low-osmolar dimeric radiographic contrast agent. GE-145 exhibits similar preclinical properties to other dimeric radiographic contrast media. In addition, the low osmolality enables an iso-osmolar f

Iosimenol is an amidobenzoic acid and a contrast agent.

Metrizamide is a nonionic radiopaque contrast agent.

p-SCN-Bn-HOPO is an excellent bifunctional chelating agent for (89)Zr ImmunoPET, with low background, good tumor-organ contrast, and importantly, very low bone uptake for BT474 breast cancer imaging.

Sprodiamide is a magnetic susceptibility-based MRI contrast agent.

Tyropanoate Sodium is a radioactive contrast agent used for cholecystography (X-ray diagnosis of gallstones).

WIN-68056 is a wetting agent in x-ray contrast compositions.